Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns
""
Blog |
13 April 2021

The Access Blog

""
Hiral Naik is the Africa Programme Manager at ‘Save The Snakes’, an organisation dedicated to mitigating human-snake conflict globally. Hiral is currently running a snake education and outreach project in South Africa in collaboration with the Hoedspruit Reptile Centre.
Blog
Blog |
29 January 2024
Tropical & neglected diseases

World NTD Day: How community voices are essential to tackling the silent crisis of snakebite

To address antimicrobial resistance, MSF launched its “Mini-Lab” initiative in Bentiu, Unity State, South Sudan. Mini-Lab is a transportable, self-contained, quality-assured, bacteriology laboratory that will significantly improve diagnosis relevance and treatment effectiveness.
Blog
Blog |
23 November 2023
Antimicrobial resistance

Bridging the Antimicrobial Access Gap: Data, Accountability, and Solutions

Improving access to insulin pens for people living with diabetes
Blog
Blog |
14 November 2023
Diabetes

World Diabetes Day: how insulin pens can improve the lives of people living with diabetes

Medium blog cover image
Blog
Blog |
10 November 2023
Diabetes

DNDi: 20 years of delivering treatments for neglected patients

Bottle of bedaquiline, Zhytomyr Regional TB Dispensary, Ukraine. In 2018, MSF started providing treatment for drug-resistant TB to people in Zhytomyr, Ukraine.
Blog
Blog |
15 September 2023
Tuberculosis

The long and winding road to ensure affordable access to a key TB drug

A baby is vaccinated against measles and whooping cough by a member of MSF’s emergency team in Satema, in the south of Central African Republic
Blog
Blog |
28 April 2023
Vaccines

Injustice for a new generation of ‘zero-dose’ children

MSF collaborated with local NGOs to support vulnerable groups during the COVID Omicron wave, Hong Kong, March 2022.
Blog
Blog |
13 March 2023
COVID-19

Amid scarcity and soaring prices, China could issue compulsory license for Paxlovid

Dr Zulfiya Dustmatova works as a medical doctor with MSF in Tajikistan, where our teams work with the Ministry of Health and Social Protection to diagnose and treat children with drug-resistant TB (DR-TB).
Blog
Blog |
01 March 2023
Tuberculosis

One step at a time: Improving treatment options for children with drug-resistant TB in Tajikistan

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury